RANKing c-Jun in osteoclast development

Journal of Clinical Investigation

Volumn 114, Issue 4, 2004, Pages 463-465

  Teitelbaum, Steven L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C JUN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; CARRIER PROTEIN; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; NUCLEAR PROTEIN; PROTEIN; PROTEIN C FOS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

CELL ACTIVITY; CELL MATURATION; CHEMICAL REACTION; HUMAN; MOLECULAR RECOGNITION; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; REACTOR CASCADE; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOLOGICAL MODEL; METABOLISM; NOTE;

ANIMALS; CARRIER PROTEINS; DNA-BINDING PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; OSTEOCLASTS; PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 4344561509     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200422644     Document Type: Review

References (21)

1. Ikeda, F., et al. 2004. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest 114:475-484, doi:10.1172/JCI200419657.
2. Teitelbaum, S.L. 2000. Bone resorption by osteoclasts. Science. 289:1504-1508.
3. Walker, D.G. 1975. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science. 190:784-785.
4. Udagawa, N., et al. 1990. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. U. S. A. 87:7260-7264.
5. Lacey, D.L., et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165-176.
6. Yasuda, H., et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/ RANKL. Proc. Natl. Acad. Sci. U. S. A. 95:3597-3602.
7. Lam, J., Nelson, C.A., Ross, F.P., Teitelbaum, S.L., and Fremont, D.L. 2001. Crystal structure of TRANCE/ RANKL cytokine reveals determinants of receptor-ligand specificity. J. Clin. Invest. 108:971-980. doi:10.1172/ JCI200113890.
8. Lam, J., et al. 2000. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106:1481-1488.
9. Li, J., et al. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U. S. A. 97:1566-1571.
10. Boyle, W.J., Simonet, W.S., and Lacey, D.L. 2003. Osteoclast differentiation and activation. Nature. 15:337-342.
11. Grigoriadis, A.E., et al. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 266:443-448.
12. Lomaga, M.A., et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1015-1024.
13. Naito, A., et al. 1999. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 4:353-362.
14. David, J.-P., Sabapathy, K., Hoffmann, O., Idarraga, M.H., and Wagner, E.F. 2002. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell. Sci. 115:4317-4325.
15. Kenner, L., et al. 2004. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J. Cell Biol. 164:613-623.
16. Matsuo, K., et al. 2000. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24:184-187.
17. Takayanagi, H., et al. 2002, Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 3:889-901.
18. Macian, F., Lopez-Rodriguez, C., and Rao, A. 2001. Partners in transcription: NFAT and AP-1. Oncogene. 20:2476-2489.
19. Zhou, B., et al. 2002. Regulation of the Murine Nfatc1 Gene by NFATc2. J. Biol. Chem. 277:10704-10711.
20. Srivastava, S., et al. 2000. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J. Biol. Chem. 276:8836-8840. doi:10.1074/jbc.M010764200.
21. Eghbali-Fatourechi, G., et al. 2003. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111:1221-1230. doi:10.1172/JCI200317215.